A Drug-drug Interaction (DDI) Study to Assess the Effect of INC280 on the Pharmacokinetics of Digoxin and Rosuvastatin in Patients With cMET-dysregulated Advanced Solid Tumors
Clinical trial NCT02626234 · COMPLETED
Trial details
- NCT number
- NCT02626234
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-08
- Primary completion
- 2017-02-28
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.